You are here：
HOME>History
History
2016
List its shares on the New Third Board, the over-the-counter (OTC) stock exchange in china, stock code:837709.
Registered capital of Seebio was increased to RMB 19,500,000.
Seebio launched its B2C website www.allinno.com.
2011
Registered capital of Seebio was increased to RMB 12,180,000.
2010
Seebio upgraded its ERP and CRM.
2009
Seebio launched its B2C website www.seebio.cn.
Facing a global economic crisis, Seebio calmly dealt with an opposite blooming.
A R&D platform of new medicine, healthcare products and biotechnique, mainly composed of Shanghai Shangela Pharm Science and Technologies Co., Ltd., was established, which set up a stragetic cooperative relationship with the Academy of Drugs in Shanghai Jiao Tong Univerisity.
2007
The biological portal, www.cnbio.net, opened to the public.
2006.6
Shanghai Seebio Biotech, Inc. moved into Shanghai 1st Center on Bisheng Road.
A R&D and production joint-venture of vitamin K and tranditional Chinese medicine monomer was established in Yunnan.
The registration of the trademarks, “ Canmedo” and “康美多”, in healthcare products was granted.
2005.5
The registration of the trademarks, “Seebio”and “西宝”, in life science products was granted.
2003.6
Shanghai Seebio Biotech, Inc. was registered in Zhangjiang Hi-Tech Park.
2002
The first website of our company, www.cxbio.com, opened to the public.
1999.9
The foundation of Xiamen API INC. was witnessed by the world.
